Across TCGA pan-cancer cohorts, RPS3AP47 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RPS3AP47 data layer.
The strongest signal is observed in thyroid carcinoma (THCA), where higher RPS3AP47 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RPS3AP47 expression acts as an unfavorable survival marker, although some lineages such as THCA and SKCM show a favorable association.
THCA, ACC, and SKCM are the cancer types where RPS3AP47 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.